These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23505965)

  • 1. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
    Yin Z; Comellas-Aragones M; Chowdhury S; Bentley P; Kaczanowska K; Benmohamed L; Gildersleeve JC; Finn MG; Huang X
    ACS Chem Biol; 2013; 8(6):1253-62. PubMed ID: 23505965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.
    Sungsuwan S; Wu X; Huang X
    Methods Enzymol; 2017; 597():359-376. PubMed ID: 28935111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.
    Yin Z; Nguyen HG; Chowdhury S; Bentley P; Bruckman MA; Miermont A; Gildersleeve JC; Wang Q; Huang X
    Bioconjug Chem; 2012 Aug; 23(8):1694-703. PubMed ID: 22812480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
    Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
    ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
    Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X
    ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure Guided Design of Bacteriophage Qβ Mutants as Next Generation Carriers for Conjugate Vaccines.
    Sungsuwan S; Wu X; Shaw V; Kavunja H; McFall-Boegeman H; Rashidijahanabad Z; Tan Z; Lang S; Tahmasebi Nick S; Lin PH; Yin Z; Ramadan S; Jin X; Huang X
    ACS Chem Biol; 2022 Nov; 17(11):3047-3058. PubMed ID: 35142488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective Synthesis of Sialyl Lewis
    Rashidijahanabad Z; Ramadan S; O'Brien NA; Nakisa A; Lang S; Crawford H; Gildersleeve JC; Huang X
    Angew Chem Int Ed Engl; 2023 Nov; 62(47):e202309744. PubMed ID: 37781858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor Humoral and T Cell Responses by Mucin-1 Conjugates of Bacteriophage Qβ in Wild-type Mice.
    Yin Z; Wu X; Kaczanowska K; Sungsuwan S; Comellas Aragones M; Pett C; Yu J; Baniel C; Westerlind U; Finn MG; Huang X
    ACS Chem Biol; 2018 Jun; 13(6):1668-1676. PubMed ID: 29782143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
    Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
    Qin Q; Yin Z; Wu X; Haas KM; Huang X
    Biomaterials; 2016 Sep; 101():189-98. PubMed ID: 27294537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
    Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
    Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.
    Yin Z; Dulaney S; McKay CS; Baniel C; Kaczanowska K; Ramadan S; Finn MG; Huang X
    Chembiochem; 2016 Jan; 17(2):174-80. PubMed ID: 26538065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic.
    Wilson RM; Danishefsky SJ
    J Am Chem Soc; 2013 Oct; 135(39):14462-72. PubMed ID: 23944352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-based cancer vaccines: target cancer with sugar bullets.
    Liu CC; Ye XS
    Glycoconj J; 2012 Aug; 29(5-6):259-71. PubMed ID: 22669462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
    O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
    Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.
    Wang Q; Zhou Z; Tang S; Guo Z
    ACS Chem Biol; 2012 Jan; 7(1):235-40. PubMed ID: 22013921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.
    Miermont A; Barnhill H; Strable E; Lu X; Wall KA; Wang Q; Finn MG; Huang X
    Chemistry; 2008; 14(16):4939-47. PubMed ID: 18431733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
    Rosenbaum P; Artaud C; Bay S; Ganneau C; Campone M; Delaloge S; Gourmelon C; Loirat D; Medioni J; Pein F; Sablin MP; Tredan O; Varga A; Leclerc C
    Cancer Immunol Immunother; 2020 May; 69(5):703-716. PubMed ID: 32034426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.